Literature DB >> 25492927

Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells.

Jen X Xu1, Tzong-Shi Lu1, Suyan Li2, Yong Wu1, Lai Ding3, Bradley M Denker4, Joseph V Bonventre1, Tianqing Kong5.   

Abstract

Interaction of polycystin-1 (PC1) and Gα12 is important for development of kidney cysts in autosomal dominant polycystic kidney disease (ADPKD). The integrity of cell polarity and cell-cell adhesions (mainly E-cadherin-mediated adherens junction) is altered in the renal epithelial cells of ADPKD. However, the key signaling pathway for this alteration is not fully understood. Madin-Darby canine kidney (MDCK) cells maintain the normal integrity of epithelial cell polarity and adherens junctions. Here, we found that deletion of Pkd1 increased activation of Gα12, which then promoted the cystogenesis of MDCK cells. The morphology of these cells was altered after the activation of Gα12. By using liquid chromatography-mass spectrometry, we found several proteins that could be related this change in the extracellular milieu. E-cadherin was one of the most abundant peptides after active Gα12 was induced. Gα12 activation or Pkd1 deletion increased the shedding of E-cadherin, which was mediated via increased ADAM10 activity. The increased shedding of E-cadherin was blocked by knockdown of ADAM10 or specific ADAM10 inhibitor GI254023X. Pkd1 deletion or Gα12 activation also changed the distribution of E-cadherin in kidney epithelial cells and caused β-catenin to shift from cell membrane to nucleus. Finally, ADAM10 inhibitor, GI254023X, blocked the cystogenesis induced by PC1 knockdown or Gα12 activation in renal epithelial cells. Our results demonstrate that the E-cadherin/β-catenin signaling pathway is regulated by PC1 and Gα12 via ADAM10. Specific inhibition of this pathway, especially ADAM10 activity, could be a novel therapeutic regimen for ADPKD.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  ADAM10; ADPKD; E-cadherin; G proteins; polycystin-1

Mesh:

Substances:

Year:  2014        PMID: 25492927      PMCID: PMC4313070          DOI: 10.1152/physiolgenomics.00090.2014

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  69 in total

1.  Impaired formation of desmosomal junctions in ADPKD epithelia.

Authors:  Ryan J Russo; Hervé Husson; Dominique Joly; Nikolay O Bukanov; Natacha Patey; Bertrand Knebelmann; Oxana Ibraghimov-Beskrovnaya
Journal:  Histochem Cell Biol       Date:  2005-09-27       Impact factor: 4.304

2.  Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins.

Authors:  Y Huan; J van Adelsberg
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

3.  Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.

Authors:  Sarah K Johnson; Vishnu C Ramani; Leah Hennings; Randy S Haun
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

4.  H2O2 activates G protein, α 12 to disrupt the junctional complex and enhance ischemia reperfusion injury.

Authors:  Wanfeng Yu; Sarah Beaudry; Hideyuki Negoro; Ilene Boucher; Mei Tran; Tianqing Kong; Bradley M Denker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 5.  Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology.

Authors:  Michael Sutters; Gregory G Germino
Journal:  J Lab Clin Med       Date:  2003-02

6.  Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin.

Authors:  S Wu; K C Lim; J Huang; R F Saidi; C L Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 7.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Gene of the month: E-cadherin (CDH1).

Authors:  Tamara M H Gall; Adam E Frampton
Journal:  J Clin Pathol       Date:  2013-08-12       Impact factor: 3.411

9.  Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta -catenin release.

Authors:  T E Meigs; T A Fields; D D McKee; P J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

10.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  5 in total

Review 1.  A cut above (and below): Protein cleavage in the regulation of polycystin trafficking and signaling.

Authors:  Valeria Padovano; Kavita Mistry; David Merrick; Nikolay Gresko; Michael J Caplan
Journal:  Cell Signal       Date:  2020-04-10       Impact factor: 4.315

2.  Gα12 is required for renal cystogenesis induced by Pkd1 inactivation.

Authors:  Yong Wu; Jen X Xu; Wassim El-Jouni; Tzongshi Lu; Suyan Li; Qingyi Wang; Mei Tran; Wanfeng Yu; Maoqing Wu; Ivan E Barrera; Joseph V Bonventre; Jing Zhou; Bradley M Denker; Tianqing Kong
Journal:  J Cell Sci       Date:  2016-08-05       Impact factor: 5.285

3.  Renal ADAM10 and 17: Their Physiological and Medical Meanings.

Authors:  Takashi Kato; Man Hagiyama; Akihiko Ito
Journal:  Front Cell Dev Biol       Date:  2018-11-06

4.  ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p.

Authors:  Quan Yuan; Honghao Yu; Jianhua Chen; Xiaoyu Song; Li Sun
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

Review 5.  Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases.

Authors:  Michele Andreucci; Michele Provenzano; Teresa Faga; Ashour Michael; Gemma Patella; Pasquale Mastroroberto; Giuseppe Filiberto Serraino; Umberto Marcello Bracale; Nicola Ielapi; Raffaele Serra
Journal:  Biomolecules       Date:  2021-01-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.